Clarivate (NYSE:CLVT) Shares Break Above 50 Day Moving Average – Should You Sell?

Clarivate PLC (NYSE:CLVT)’s share price passed above its fifty day moving average during trading on Tuesday. The stock has a fifty day moving average of $1.81 and traded as high as $2.1050. Clarivate shares last traded at $2.0660, with a volume of 11,847,923 shares changing hands.

Trending Headlines about Clarivate

Here are the key news stories impacting Clarivate this week:

• Positive Sentiment: Clarivate reported Q3 adjusted earnings of $0.21 per share, above analyst estimates of roughly $0.18–$0.19 and up from $0.18 a year earlier. Management also cited improved organic recurring revenue growth and a return to positive annual contract value growth in Intellectual Property. Clarivate Q3 results
• Positive Sentiment: The company anticipates 10%–15% free-cash-flow growth in 2027 following the Life Sciences & Healthcare sale, offering investors a potentially encouraging view of cash generation after the portfolio change. 2027 free cash flow outlook
• Positive Sentiment: Clarivate announced an alliance to make its CompuMark trademark data available in Microsoft Copilot through IPOne. The partnership could expand the reach of its intellectual-property information in AI-enabled workflows, though financial benefits were not specified. Microsoft Copilot partnership
• Negative Sentiment: Revenue was $481.6 million, well below the roughly $566.8 million consensus estimate and down 22.7% year over year. The sharp miss tempers the EPS beat and raises questions about the pace and quality of the company’s recovery. Q3 earnings coverage

Analysts Set New Price Targets

Several analysts have recently weighed in on the company. Morgan Stanley initiated coverage on Clarivate in a report on Friday, October 30th. They set an “underweight” rating and a $1.50 price objective on the stock. William Blair cut Clarivate to a “market perform” rating in a research report on Thursday, October 15th. The Goldman Sachs Group cut their target price on Clarivate from $2.90 to $2.60 and set a “neutral” rating for the company in a research note on Thursday, July 30th. Weiss Ratings restated a “sell (e+)” rating on shares of Clarivate in a research note on Monday, September 21st. Finally, Stifel Nicolaus reduced their target price on Clarivate from $6.00 to $5.00 and set a “buy” rating for the company in a research report on Thursday, July 30th. One investment analyst has rated the stock with a Buy rating, four have issued a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Reduce” and a consensus price target of $2.77.

Clarivate Stock Performance

The company has a market capitalization of $1.32 billion, a P/E ratio of -3.97 and a beta of 1.38. The stock has a fifty day simple moving average of $1.81 and a 200-day simple moving average of $2.22. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.93.

Clarivate (NYSE:CLVT) last issued its earnings results on Tuesday, November 3rd. The company reported $0.21 EPS for the quarter, beating the consensus estimate of $0.18 by $0.03. Clarivate had a negative net margin of 13.84% and a positive return on equity of 9.15%. The company had revenue of $481.60 million for the quarter, compared to the consensus estimate of $566.77 million. During the same quarter in the previous year, the company earned $0.18 EPS. The firm’s revenue for the quarter was down 22.7% compared to the same quarter last year. Equities analysts forecast that Clarivate PLC will post 0.67 EPS for the current year.

Insider Transactions at Clarivate

In other news, Director Kenneth Cornick purchased 650,000 shares of Clarivate stock in a transaction on Thursday, August 6th. The shares were purchased at an average cost of $1.86 per share, for a total transaction of $1,209,000.00. Following the completion of the transaction, the director directly owned 1,750,000 shares in the company, valued at approximately $3,255,000. This represents a 59.09% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 22.88% of the stock is owned by corporate insiders.

Institutional Trading of Clarivate

Hedge funds have recently modified their holdings of the company. Abacus Wealth Partners LLC bought a new position in shares of Clarivate in the third quarter valued at approximately $42,000. Commonwealth Equity Services LLC acquired a new position in shares of Clarivate in the 3rd quarter worth approximately $30,000. Vise Technologies Inc. boosted its holdings in shares of Clarivate by 50.4% in the 3rd quarter. Vise Technologies Inc. now owns 37,327 shares of the company’s stock worth $62,000 after acquiring an additional 12,512 shares in the last quarter. State of Wyoming grew its position in Clarivate by 120.1% during the 3rd quarter. State of Wyoming now owns 170,100 shares of the company’s stock worth $284,000 after acquiring an additional 92,811 shares during the last quarter. Finally, WINTON GROUP Ltd bought a new stake in Clarivate during the 2nd quarter worth approximately $114,000. Institutional investors and hedge funds own 85.72% of the company’s stock.

About Clarivate

Clarivate Plc (NYSE:CLVT) provides analytics, data, and workflow solutions to organizations in academia, government, research, life sciences, and intellectual property. Its offerings are designed to help customers evaluate research, manage information, accelerate innovation, and support strategic decision-making.

The company’s products include Web of Science research databases and citation analytics, InCites research evaluation tools, Derwent innovation and patent intelligence services, and Cortellis life sciences and drug-development information.